Biotage AB (publ) (LON: 0GRP)

Market Cap	810.69M
Revenue (ttm)	155.73M
Net Income (ttm)	18.91M
Shares Out	n/a
EPS (ttm)	0.24
PE Ratio	42.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Apr 26, 2024

Volume	9,838
Average Volume	3,122
Open	137.15
Previous Close	137.15
Day's Range	137.00 - 139.80
52-Week Range	8.90 - 14.57
Beta	0.91
RSI	31.22
Earnings Date	Feb 19, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicol...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 674
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GRP

Financial Performance

In 2023, Biotage AB's revenue was 1.86 billion, an increase of 18.90% compared to the previous year's 1.57 billion. Earnings were 246.00 million, a decrease of -8.21%.

Financial numbers in SEK